SUB1 - SUB1 regulator of transcription Gene
Also Known as P15; PC4; p14
Species: Homo sapiens
Gene Type: protein coding
Gene ID: 10923
About SUB1
Cytogenetic location: 5p13.3
Genomic coordinates (GRCh38): 5:32,585,557-32,604,079 (from NCBI)
This gene has 13 transcripts (splice variants) and 228 orthologues. Ubiquitous expression in brain (RPKM 41.5), fat (RPKM 34.4) and 25 other tissues.
Summary
Enables identical protein binding activity; single-stranded DNA binding activity; and transcription coactivator activity. Involved in negative regulation of DNA metabolic process and regulation of transcription by RNA polymerase II. Located in nucleolus and nucleoplasm. Part of transcription regulator complex. [provided by Alliance of Genome Resources, Apr 2022]
SUB1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_006713.4 | NP_006704.3 | activated RNA polymerase II transcriptional coactivator p15 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables identical protein binding |
IPI
IPI: Inferred from physical interaction
|
16415882 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
9847329 | GOA |
| enables single-stranded DNA binding |
IDA
IDA: Inferred from direct assay
|
8062391 | GOA |
| enables transcription coactivator activity |
IDA
IDA: Inferred from direct assay
|
8062391 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in RNA polymerase II promoter clearance |
IDA
IDA: Inferred from direct assay
|
25308091 | GOA |
| involved in negative regulation of DNA duplex unwinding |
IDA
IDA: Inferred from direct assay
|
16605275 | GOA |
| involved in negative regulation of DNA metabolic process |
IDA
IDA: Inferred from direct assay
|
28369605 | GOA |
| involved in regulation of transcription by RNA polymerase II |
IDA
IDA: Inferred from direct assay
|
8062391 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| part of transcription regulator complex |
IDA
IDA: Inferred from direct assay
|
8062391 | GOA |
EXP: Inferred from Experiment
IDA: Inferred from direct assay
IPI: Inferred from physical interaction
IMP: Inferred from mutant phenotype
IGI: Inferred from genetic interaction
IEP: Inferred from expression pattern
SUB1 Protein Structure
PC4
PC4: Transcriptional Coactivator p15 (PC4) (63 - 116)
- 0
- 100
- 127 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
activated RNA polymerase II transcriptional coactivator p15 |
|
SUB1 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
SUB1 | P53999 | CSTF2 | Homo sapiens | P33240-1 | 11389848 | |
|
Intra
|
SUB1 | P53999 | SUB1 | Homo sapiens | P53999 | 16415882 | |
|
Intra
|
SUB1 | P53999 | SUB1 | Homo sapiens | P53999 | 32296183 | |
|
Intra
|
SUB1 | P53999 | SUB1 | Homo sapiens | P53999 | 25416956 | |
|
Intra
|
SUB1 | P53999 | SUB1 | Homo sapiens | P53999 | 32296183 | |
|
Intra
|
SUB1 | P53999 | SUB1 | Homo sapiens | P53999 | 32296183 |
Cross: Cross-species interaction
Intra: Intraspecies interaction
Recombinant SUB1 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P74650 | PC4/SUB1 Protein, Human (His) | P53999 (M1-L127) | ≥ 95%, as determined by reducing SDS-PAGE. |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Dyskeratosis Congenita, Autosomal Recessive 5 |
|
|
| Tinea Manuum |
|
|
| Cri-Du-Chat Syndrome |
|
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-13956A | (R)-Pioglitazone-d1 | / | Phase 2 | |
| HY-W865379 | (S)-Avadomide-d1 | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(400)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-15176B | Pyridostatin TFA | 99.17% | Unkown | |
| HY-B0892S4 | Benzyl alcohol-d1 | 95.66% | Unkown | |
| HY-W142820S | 1,1,3,3-Tetraethoxypropane-d2 | 99.23% | Unkown | |
| HY-B0228S | Adenosine-d1 | 99.97% | Unkown | |
| HY-130462S | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d31 | 99.0% | Unkown | |
| HY-146726S | Tripentadecanoin-d29 | 99.24% | Unkown | |
| HY-W040193S | DSPC-d70 | 99.93% | Unkown | |
| HY-15176C | Pyridostatin trihydrochloride | 99.85% | Unkown | |
| HY-13966S | 2-Deoxy-D-glucose-d1 | 98.0% | Unkown | |
| HY-B0389S2 | D-Glucose-d12-1 | 99.47% | Unkown | |
| HY-W013049S4 | Docosanoic acid-d4-1 | Inhibitor | 99.26% | Unkown |
| HY-90006S | 5-Fluorouracil-d1 | 99.9% | Unkown | |
| HY-W050145S | Levoglucosan-d7 | 99.90% | Unkown | |
| HY-113123S1 | LysoPC(14:0/0:0)-d7 | 95.40% | Unkown | |
| HY-B0151S2 | Pregnenolone-d4-1 | 99.34% | Unkown | |
| HY-B0152S | Adenine-d1 | Chemical | 99.91% | Unkown |
| HY-Y1275S | N-Methylpyrrolidone-d9 | 98% | Unkown | |
| HY-Y0921S | (±)-1,2-Propanediol-d8 | 99.55% | Unkown | |
| HY-122277S | 1'-Hydroxy bufuralol-d9 | 99.9% | Unkown | |
| HY-Y1039S1 | 1-Stearoyl-rac-glycerol-d35 | 99.91% | Unkown | |
| HY-143671S | 1-Stearoyl-2-arachidonoyl-sn-glycero-3-PE-d11 | 99.0% | Unkown | |
| HY-15780S1 | Brexpiprazole-d8-1 | 96.48% | Unkown | |
| HY-N7092S11 | D-Fructose-d-1 | 98.0% | Unkown | |
| HY-W768340 | Sucrose-13C6-1 | 99.90% | Unkown | |
| HY-125783S1 | 1-Palmitoyl-sn-glycero-3-phosphocholine-d31 | 99.94% | Unkown | |
| HY-125783S3 | 1-Palmitoyl-sn-glycero-3-phosphocholine-d9-1 | 95.0% | Unkown | |
| HY-125771S | 1-Stearoyl-sn-glycero-3-phosphocholine-d35 | 99% | Unkown | |
| HY-B0389S1 | D-Glucose-d1 | 99.86% | Unkown | |
| HY-B0402S | Amantadine-d15 | 98.13% | Unkown | |
| HY-W014286S | 1,3-Diphenylurea-d10 | 99% | Unkown | |
| HY-W242724 | 1,4-Dibromo-butane-d8 | 99.91% | Unkown | |
| HY-Y0921S2 | (±)-1,2-Propanediol-d6 | 99.97% | Unkown | |
| HY-113424AS | 1,2-Dioleoyl-sn-glycero-3-phosphocholine-d9 | 98.0% | Unkown | |
| HY-W032013S | 1-Octanol-d17 | 99.09% | Unkown | |
| HY-W050145S2 | Levoglucosan-13C6 | 99.7% | Unkown | |
| HY-100442S1 | Paquinimod-d5-1 | Inhibitor | 98.19% | Unkown |
| HY-10162S3 | Olaparib-d4-1 | 98.82% | Unkown | |
| HY-10585S4 | Valproic acid-d4-1 | 99.5% | Unkown | |
| HY-113139S | 1-Methylinosine-d3 | 99.0% | Unkown | |
| HY-13936S | 1-Methylimidazoleacetic acid-d3 | / | Unkown | |
| HY-14648S5 | Dexamethasone-d3-1 | 98.02% | Unkown | |
| HY-76025S | 1,4-Dibromobenzene-d4 | 99.94% | Unkown | |
| HY-B0234S4 | Estrone-d2-1 | Agonist | 99.75% | Unkown |
| HY-B0389S8 | D-Glucose-d1-4 | 98.0% | Unkown | |
| HY-B0166S8 | L-Ascorbic acid-13C6-1 | 99.37% | Unkown | |
| HY-B0389S7 | D-Glucose-d1-3 | 99.90% | Unkown | |
| HY-N0229S16 | L-Alanine-d3-1 | 99.0% | Unkown | |
| HY-W004051S | 1-Bromo-2-chlorobenzene-d4 | 99.75% | Unkown | |
| HY-W089832S | 1,1-Dimethylurea-d6 | 99.61% | Unkown | |
| HY-W097453S2 | 6-(Methylthio)purine-d3-1 | 99.56% | Unkown | |
| HY-N0488S1 | Vincristine-d3-1 sulfate | 99.59% | Unkown | |
| HY-107343S1 | Docosahexaenoic acid ethyl ester-d5-1 | / | Unkown | |
| HY-109128S2 | Danicamtiv-d3-1 | / | Unkown | |
| HY-109506S3 | DPPC-d9-1 | ≥99.0% | Unkown | |
| HY-115702S | 1-Palmityl-2-O-acetyl-3-glyceryl phosphorylcholine-d4 | Agonist | ≥99.0% | Unkown |
| HY-12222S1 | Obeticholic acid-d4-1 | Agonist | 99.84% | Unkown |
| HY-15025S2 | Sildenafil-d3-1 | 99.47% | Unkown | |
| HY-153939S | Idasanutlin-d3-1 | 99.57% | Unkown | |
| HY-17376S1 | Ezetimibe-d4-1 | 99.26% | Unkown | |
| HY-34705S | Dimethyl sulfoxide-d6 | 98.0% | Unkown | |
| HY-70057S1 | Safinamide-d4-1 | Inhibitor | 98.90% | Unkown |
| HY-A0070AS2 | Liothyronine-13C6-1 | Agonist | 98.06% | Unkown |
| HY-B0228S8 | Adenosine-d1-2 | 99.72% | Unkown | |
| HY-B0389S4 | D-Glucose-d1-2 | 99.92% | Unkown | |
| HY-B0402S1 | Amantadine-d6 | 99.86% | Unkown | |
| HY-B0511S | Biotin-d2-1 | 99.65% | Unkown | |
| HY-B1411S1 | i-Inositol-d1 | 99.46% | Unkown | |
| HY-N0210S11 | D-Galactose-d2-1 | 99.9% | Unkown | |
| HY-N0210S7 | D-Galactose-d1-2 | / | Unkown | |
| HY-N0229S4 | L-Alanine-13C,d1 | 99.96% | Unkown | |
| HY-W004263S | 1-Eicosanol-d41 | 98.8% | Unkown | |
| HY-W004292S | 1-Undecanol-d23 | 98.2% | Unkown | |
| HY-W009719S | 1-Bromo-2,3-dichlorobenzene-d3 | / | Unkown | |
| HY-W010004S | 1-Bromo-3-chlorobenzene-d4 | / | Unkown | |
| HY-W013504S | 1-Bromo-4-(trifluoromethyl)benzene-d4 | / | Unkown | |
| HY-W032013S1 | 1-Octanol-d2 | 99.0% | Unkown | |
| HY-W654064 | Azithromycin-13C,d3-1 | 99.9% | Unkown | |
| HY-W726845 | 1-Methyl-4-nitrosopiperazine-d11 | 97.57% | Unkown | |
| HY-Y0308S | Phosphate dibasic-d1sodium | 99.0% | Unkown | |
| HY-Y1004S4 | 1-Decanol-d4 | / | Unkown | |
| HY-Y1217S1 | 1-Cyclohexanol-d11 | / | Unkown | |
| HY-109541S2 | Colfosceril miristate-d9 | 99.0% | Unkown | |
| HY-113136S | 1-Methylguanosine-d3 | 99.50% | Unkown | |
| HY-33948S | 1-Amino-2-methylpropan-2-ol-d6 | / | Unkown | |
| HY-B0260S6 | Methylprednisolone-d3-1 | / | Unkown | |
| HY-W012934S | 1-Ethylpyrrolidin-2-one-d5 | / | Unkown | |
| HY-W015301S1 | Dimethyl adipate-d4-1 | 99.40% | Unkown | |
| HY-W040193S3 | DSPC-d83 | 99.0% | Unkown | |
| HY-W040193S4 | DSPC-d4 | 99.0% | Unkown | |
| HY-W1115209 | 1,3,5-Tribromo-2-iodobenzene-d2 | / | Unkown | |
| HY-W115741S | 1-Phenylethanamine-d3 | / | Unkown | |
| HY-W725472 | 1,3-Dibromobenzene-d4 | / | Unkown | |
| HY-Y0566S | 1,4-Diazabicyclo[2.2.2]octane-d12 | 99.60% | Unkown | |
| HY-Y1052S | N-Dodecylbenzene-d30 | 98.1% | Unkown | |
| HY-Y1806S1 | 1,3-Dibromopropane-d6 | / | Unkown | |
| HY-109025AS2 | Baloxavir-d1 | Inhibitor | / | Unkown |
| HY-12215S2 | Deulorlatinib | 99.84% | Unkown | |
| HY-125783S2 | 1-Palmitoyl-sn-glycero-3-phosphocholine-d49 | 99% | Unkown | |
| HY-Y0479S3 | L-Lactic acid-2-13C1 | Inhibitor | / | Unkown |
| HY-15029S1 | (±)-Naproxen-d3-1 | / | Unkown | |
| HY-W013376S | Norcyclizine-d8 | / | Unkown | |
| HY-10002AS | (1S)-Calcitriol-d3 | / | Unkown | |
| HY-10002AS2 | (1S)-Calcitriol-d6 | / | Unkown | |
| HY-10003S | Alfacalcidol-d7 | Activator | / | Unkown |
| HY-100441S1 | Treprostinil-13C2,d1 | Inhibitor | / | Unkown |
| HY-100641S1 | 4-Hydroxytolbutamide-d9-1 | / | Unkown | |
| HY-10284S3 | Linagliptin-d3-1 | / | Unkown | |
| HY-10585AS2 | Valproic acid-d4-1 sodium | / | Unkown | |
| HY-107737S | 1,2-DLPC-d55 | / | Unkown | |
| HY-107737S2 | 1,2-DLPC-d46 | / | Unkown | |
| HY-107737S3 | 1,2-DLPC-d9 | / | Unkown | |
| HY-10846S1 | Delamanid-d4-1 | / | Unkown | |
| HY-108506S2 | Licarbazepine-d4-1 | Inhibitor | 99.28% | Unkown |
| HY-109127S | Berotralstat-d4-1 | Inhibitor | / | Unkown |
| HY-109541S | Colfosceril miristate-d58 | 99.3% | Unkown | |
| HY-109541S1 | Colfosceril miristate-d4 | / | Unkown | |
| HY-109541S3 | Colfosceril miristate-d13 | / | Unkown | |
| HY-109541S4 | Colfosceril miristate-d63 | / | Unkown | |
| HY-109541S5 | Colfosceril miristate-d67 | 99.0% | Unkown | |
| HY-11018S1 | Risperidone-d4-1 | / | Unkown | |
| HY-112005S | DOPE-d62 | / | Unkown | |
| HY-112530S | 1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine-d70 | 99.0% | Unkown | |
| HY-113958S1 | Difethialone-d4-1 | Inhibitor | / | Unkown |
| HY-114041S1 | Resolvin E1-d4-1 | / | Unkown | |
| HY-115705S | 1,2,3-Tri-10(Z)-Heptadecenoyl Glycerol-d5 | / | Unkown | |
| HY-122056S | 1,2-Diheptanoyl-SN-glycero-3-phosphocholine-d35 | / | Unkown | |
| HY-122056S1 | 1,2-Diheptanoyl-SN-glycero-3-phosphocholine-d26 | / | Unkown | |
| HY-122272S2 | Paroxetine-d6-1 | / | Unkown | |
| HY-122426S1 | 1-Bromoundecane-d3 | / | Unkown | |
| HY-122426S2 | 1-Bromoundecane-d4 | 98.8% | Unkown | |
| HY-12516S2 | Desogestrel-13C2,d2-1 | / | Unkown | |
| HY-125783S | 1-Palmitoyl-sn-glycero-3-phosphocholine-d9 | / | Unkown | |
| HY-12650S | Mirogabalin-13C2,d1 (Mixture of Diastereomers) | / | Unkown | |
| HY-126967AS | 1-Palmitoyl-sn-glycerol 3-phosphate-d9 | / | Unkown | |
| HY-12987S2 | Pimozide-d4-1 | Inhibitor | / | Unkown |
| HY-130462S1 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d82 | 99% | Unkown | |
| HY-130462S4 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d9 | / | Unkown | |
| HY-130462S5 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d62 | / | Unkown | |
| HY-13571S3 | Betamethasone dipropionate-d6-1 | / | Unkown | |
| HY-135810S1 | Cletoquine-d4-1 | Inhibitor | / | Unkown |
| HY-13593S1 | Chlorambucil-d8-1 | / | Unkown | |
| HY-139609AS | (1R,3r,5S)-Camonsertib-d3 | / | Unkown | |
| HY-141919S | 1-Bromo-4-iodobenzene-13C6 | / | Unkown | |
| HY-142555S | Bisphenol A monosulfate-d6 sodium | / | Unkown | |
| HY-14281S2 | Trilostane-d3-1 | / | Unkown | |
| HY-14444S | Plinabulin-d1 | Inhibitor | / | Unkown |
| HY-145547S | 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine-d27 | / | Unkown | |
| HY-14648S1 | Dexamethasone-d5-1 | / | Unkown | |
| HY-14656S4 | Diltiazem-d4-1 hydrochloride | Antagonist | / | Unkown |
| HY-146737S | Tripentadecanoin-d5 | / | Unkown | |
| HY-146881S | Colfosceril miristate-d27 | 99.0% | Unkown | |
| HY-146894S | DSPC-d35 | 99.0% | Unkown | |
| HY-14956S1 | Nemonoxacin-d3-1 | Inhibitor | / | Unkown |
| HY-151997S | 1,2-Dioleoyl-3-lauroyl-rac-glycerol-13C3 | / | Unkown | |
| HY-152070S1 | Demethylmaprotiline-d2-1 | / | Unkown | |
| HY-15592S2 | Cabotegravir-d3-1 | Inhibitor | / | Unkown |
| HY-15917S1 | DL-Dithiothreitol-d10-1 | Inhibitor | / | Unkown |
| HY-160099S1 | 20-5,14-HEDE-d2-1 | / | Unkown | |
| HY-17386S2 | Rosiglitazone-d4-1 | / | Unkown | |
| HY-17430S1 | Amprenavir-d4-1 | Inhibitor | / | Unkown |
| HY-178403S | 1,3-Diethyl-1,3-diphenylurea-d10-1 | / | Unkown | |
| HY-178703S | 1,2-Diheptanoyl-SN-glycero-3-phosphocholine-d9 | / | Unkown | |
| HY-178735S | 1,2-Dioleoyl-sn-glycero-3-phosphocholine-d62 | / | Unkown | |
| HY-178736S | 1,2-Dilauroyl-sn-glycero-3-phosphoethanolamine-d46 | / | Unkown | |
| HY-178758S | 1-Palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine-d66 | / | Unkown | |
| HY-178787S | POPG-d62 | / | Unkown | |
| HY-178791S | 1,2-Diheptanoyl-sn-glycero-3-phosphoethanolamine-d26 | / | Unkown | |
| HY-178810S | 1,2-Dioleoyl-sn-glycero-3-phospho-L-serine-d62 ammonium | / | Unkown | |
| HY-18341S4 | L-Thyroxine-13C6-1 | / | Unkown | |
| HY-19696S2 | Tauroursodeoxycholate-d4-1 | Inhibitor | / | Unkown |
| HY-23188 | Loratadine-d5-1 | / | Unkown | |
| HY-34123S | N-(2-Bromoethyl)phthalimide-d4 | / | Unkown | |
| HY-34444S | 1,1-Dioxothiolan-d8 | 99.9% | Unkown | |
| HY-41676S | 4-Chlorobenzonitrile-d4 | / | Unkown | |
| HY-41681S | 6-Chloro-1-hexanol-d6 | 98% | Unkown | |
| HY-50898S3 | Lapatinib-d4-1 | / | Unkown | |
| HY-59354S1 | 1,2-Dihydropyridazine-3,6-dione-3,4,5,6-13C4 | Inhibitor | / | Unkown |
| HY-66008S1 | N-Acetyl mesalazine-d3-1 | / | Unkown | |
| HY-66011AS3 | Moxifloxacin-d3-1 hydrochloride | Inhibitor | / | Unkown |
| HY-79779S1 | 1-Bromo-4-(bromomethyl)benzene-d4 | / | Unkown | |
| HY-A0042S2 | Rufinamide-15N,d2-1 | Inhibitor | / | Unkown |
| HY-A0052S | (1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide-d4 | / | Unkown | |
| HY-A0095S1 | Flibanserin-d4-1 | 99.28% | Unkown | |
| HY-B0111S1 | Drospirenone-d4-1 | Agonist | / | Unkown |
| HY-B0113S1 | Omeprazole-d3-1 | Inhibitor | 95.09% | Unkown |
| HY-B0114S1 | Oxcarbazepine-d4-1 | / | Unkown | |
| HY-B0158S3 | Cytidine-d2-1 | / | Unkown | |
| HY-B0158S4 | Cytidine-d1 | / | Unkown | |
| HY-B0196S1 | Venlafaxine-d6-1 | Inhibitor | 99.9% | Unkown |
| HY-B0223S4 | Albendazole-d3-1 | / | Unkown | |
| HY-B0228S7 | Adenosine-d1-1 | 99.5% | Unkown | |
| HY-B0389S18 | D-Glucose-13C3-1 | / | Unkown | |
| HY-B0389S23 | D-Glucose-d2-1 | / | Unkown | |
| HY-B0389S25 | D-Glucose-13C,d1 | / | Unkown | |
| HY-B0389S3 | D-Glucose-d1-1 | / | Unkown | |
| HY-B0400S7 | D-Sorbitol-d1-2 | / | Unkown | |
| HY-B0400S8 | D-Sorbitol-d2-1 | / | Unkown | |
| HY-B0412S4 | Estriol-d3-1 | Antagonist | / | Unkown |
| HY-B0451AS3 | Dopamine-d2-1 hydrochloride | / | Unkown | |
| HY-B0456S1 | Riboflavin-5-Phosphate-13C4,15N2-1 | / | Unkown | |
| HY-B0561S2 | Spironolactone-d3-1 | / | Unkown | |
| HY-B0763S2 | Ibudilast-d7-1 | / | Unkown | |
| HY-B0896S1 | Triacetin-d5 | Inhibitor | / | Unkown |
| HY-B0896S2 | Triacetin-d9 | / | Unkown | |
| HY-B0901S1 | Bromperidol-d4-1 | Inhibitor | / | Unkown |
| HY-B1659S3 | Glycerol-d1 | / | Unkown | |
| HY-B1716S1 | L-5-Hydroxytryptophan-d3-1 | / | Unkown | |
| HY-G0016S1 | N-Acetyl dapsone-d4-1 | / | Unkown | |
| HY-N0131S1 | Stigmasterol-d5-1 | 99.90% | Unkown | |
| HY-N0210S12 | D-Galactose-13C,d1 | / | Unkown | |
| HY-N0210S5 | D-Galactose-d1 | / | Unkown | |
| HY-N0210S6 | D-Galactose-d1-1 | 99.55% | Unkown | |
| HY-N0210S8 | D-Galactose-d1-3 | / | Unkown | |
| HY-N0215S13 | L-Phenylalanine-d1 | Antagonist | 99.5% | Unkown |
| HY-N0378S5 | D-Mannitol-d1 | / | Unkown | |
| HY-N0384S4 | Homovanillic acid-d3-1 | / | Unkown | |
| HY-N0537S12 | Xylose-d1-3 | / | Unkown | |
| HY-N0537S13 | Xylose-d1-4 | / | Unkown | |
| HY-N0717S8 | L-Valine-d1 | 98.0% | Unkown | |
| HY-N1380S4 | Guaiacol-d4-1 | / | Unkown | |
| HY-N6709S2 | Zeranol-d5-1 | / | Unkown | |
| HY-N7092S18 | D-Fructose-d2-1 | / | Unkown | |
| HY-P10215 | Ac-{Cpg}-Thr-Ala-{Ala(CO)}-Asp-{Cpg}-NH2 | Inhibitor | / | Unkown |
| HY-RS13999 | SUB1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W004292S1 | 1-Undecanol-d4 | / | Unkown | |
| HY-W004293S | 1-Tridecanol-d27 | 98.7% | Unkown | |
| HY-W005926S | 1,5-Dimethyl-1H-pyrazole-4-carboxylic acid-d6 | / | Unkown | |
| HY-W007926S | 2-Oxobutanoic acid-13C,d2-1 | / | Unkown | |
| HY-W008625S1 | 1-Bromohexadecane-d33 | / | Unkown | |
| HY-W009141S | 1-Monopalmitin-d31 | / | Unkown | |
| HY-W009450S | 1,7-Dibromoheptane-d14 | / | Unkown | |
| HY-W009570S | 1-Bromo-4-(trifluoromethoxy)benzene-d4 | / | Unkown | |
| HY-W009981S | 1-Bromo-2,4-difluorobenzene-d3 | / | Unkown | |
| HY-W010265S | Butyrophenone-d5 | / | Unkown | |
| HY-W011883S | 1,3-Dibromo-5-fluorobenzene-d3 | / | Unkown | |
| HY-W012856S | 1-Ethyl-3-methylbenzene-d5 | / | Unkown | |
| HY-W013053S | Dibenz[a,h]anthracene-d14 | / | Unkown | |
| HY-W013948S | 1-(2,4-Dinitrophenyl)-2-propylidenehydrazine-d3 | / | Unkown | |
| HY-W014409S | 1,2,4-Benzenetricarboxylic acid-d3 | / | Unkown | |
| HY-W014431S | 1-Bromo-3-chloro-5-fluorobenzene-d3 | / | Unkown | |
| HY-W014559S3 | 1-Bromononane-d4-1 | / | Unkown | |
| HY-W014559S4 | 1-Bromononane-d5 | / | Unkown | |
| HY-W015784S | 1,4-Benzenedimethanol-d4 | 98.0% | Unkown | |
| HY-W015824S3 | DL-Aspartic acid-13C1 | / | Unkown | |
| HY-W015849S | 1-Fluoro-4-methoxybenzene-d4 | / | Unkown | |
| HY-W016249S1 | 1-Bromo-4-ethylbenzene-d5 | / | Unkown | |
| HY-W016577S3 | 1-Bromoheptane-d7 | / | Unkown | |
| HY-W016577S4 | 1-Bromoheptane-d1 | / | Unkown | |
| HY-W016931S | 1-Bromo-4-chlorobutane-d8 | / | Unkown | |
| HY-W017142S | 1-(Benzyloxy)propan-2-ol-d6 | / | Unkown | |
| HY-W017522S5 | Adipic acid-d4-1 | Inhibitor | / | Unkown |
| HY-W017554S | 1-Chloro-2-methoxybenzene-d3 | / | Unkown | |
| HY-W032015S3 | 1-Bromooctane-d4 | 98.0% | Unkown | |
| HY-W040193S2 | DSPC-d79 | 99.3% | Unkown | |
| HY-W040193S5 | DSPC-d9 | 99.0% | Unkown | |
| HY-W040193S6 | DSPC-d13 | 99.0% | Unkown | |
| HY-W048482S | rU Phosphoramidite-13C2,d1 | / | Unkown | |
| HY-W051547S | 1-(2-Chloropyridin-3-yl)ethanol-d4 | / | Unkown | |
| HY-W051547S1 | 1-(2-Chloropyridin-3-yl)ethanol-d3 | / | Unkown | |
| HY-W051547S2 | 1-(2-Chloropyridin-3-yl)ethanol-d1 | / | Unkown | |
| HY-W052227S | Fmoc-DL-Ala-OH-d1 | / | Unkown | |
| HY-W087024S | 1-Phenylpentane-d5 | / | Unkown | |
| HY-W094751S | 1-Pyrenamin-d9 | / | Unkown | |
| HY-W098448S | 1-Methylazepan-2-one-d3 | 99.7% | Unkown | |
| HY-W099504S | 1-Heptanol-d15 | 99.05% | Unkown | |
| HY-W099504S1 | 1-Heptanol-d7 | / | Unkown | |
| HY-W099504S2 | 1-Heptanol-d1 | / | Unkown | |
| HY-W099521S | 1-Chlorooctane-d17 | 99.5% | Unkown | |
| HY-W101642S | 1,3-Diisopropylbenzene-d18 | / | Unkown | |
| HY-W101971S | 1-(4-Chlorophenyl)-2-methylpropan-2-ol-d6 | / | Unkown | |
| HY-W105111S | 1-Bromo-2,3,5-trichlorobenzene-d2 | / | Unkown | |
| HY-W110702S1 | 1-Bromotridecane-d4 | 99.2% | Unkown | |
| HY-W111467S | 1-Bromoeicosane-d41 | 99.9% | Unkown | |
| HY-W111468S | 1-Iodohexadecane-d4 | / | Unkown | |
| HY-W1125030S | Ethyl acetoacetate-13C2-1 | / | Unkown | |
| HY-W130478S | 1-Phenylhexane-d5 | / | Unkown | |
| HY-W142175S | 1-Butynylbenzene-d5 | 98.6% | Unkown | |
| HY-W583868S | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PE-d62 | / | Unkown | |
| HY-W590534S | 1-Palmitoyl-sn-glycero-3-phosphocholine-d3 | / | Unkown | |
| HY-W654074 | 1,2-Dilauroyl-3-chloropropanediol-d5 | / | Unkown | |
| HY-W699416 | 1-Naphthoic acid-d7 | / | Unkown | |
| HY-W699983 | Imidazole-15N2 | Inhibitor | 98.56% | Unkown |
| HY-W700931 | 1-Methoxy-2-(2-methoxyethoxy)ethane-d6 | / | Unkown | |
| HY-W700950 | 1-(4-Chlorophenyl)cyclobutanecarbonitrile-d6 | / | Unkown | |
| HY-W709612 | Regorafenib N-oxide and N-desmethyl (M5)-d3-1 | / | Unkown | |
| HY-W711089 | Bifenox-d3-1 | / | Unkown | |
| HY-W712592 | 1-Ethylpyrrolidine-2,5-dione-d5 | / | Unkown | |
| HY-W716213 | 1-(2,4-Dimethoxyphenyl)ethanone-d6 | / | Unkown | |
| HY-W718041S | 1-Lauroyl-2-decanoyl-3-chloropropanediol-13C3 | / | Unkown | |
| HY-W718042 | 1-Lauroyl-2-decanoyl-3-chloropropanediol-d5 | / | Unkown | |
| HY-W719338 | Pentane-1,2-diol-d7 | / | Unkown | |
| HY-W720915 | N-Dodecylbenzene-d5 | / | Unkown | |
| HY-W723927 | 1-Bromohexadecane-d4 | / | Unkown | |
| HY-W723937 | 1-Bromopentadecane-d4 | / | Unkown | |
| HY-W724365 | 1-Bromo-2-methoxyethane-d3 | / | Unkown | |
| HY-W724366 | 1-Ethyl-2-methylbenzene-d5 | / | Unkown | |
| HY-W724384 | 1-Bromotridecane-d9 | / | Unkown | |
| HY-W725429 | 1,5-Dihydroxynaphthalene-d6 | / | Unkown | |
| HY-W740373 | 1-Methylpiperidin-4-ol-d4 | / | Unkown | |
| HY-W749377 | 1,2,3,4,5-Pentabromo-6-methylbenzene-13C6 | / | Unkown | |
| HY-W751665 | 1-(Adamantan-1-yl)ethan-1-one-d3 | / | Unkown | |
| HY-W752616 | 1-Aminopropan-2-ol-d6 | / | Unkown | |
| HY-W752893 | D-4-Hydroxyphenylglycine-d5-1 | / | Unkown | |
| HY-W754348 | 1-(2,6-Dimethylphenoxy)propan-2-one-d5 | / | Unkown | |
| HY-W765245 | Rapamycin-13C,d3-1 | / | Unkown | |
| HY-W766078 | 1-beta-D-Arabinofuranosyluracil-13C,15N2 | / | Unkown | |
| HY-W766801 | 1-Linoleoyl-3-chloropropanediol-d5 | / | Unkown | |
| HY-W767978 | 1-(4,4-Dimethylthiochroman-6-yl)ethanone-d8 | / | Unkown | |
| HY-W768181 | 1,5-Anhydrosorbitol-13C6 | / | Unkown | |
| HY-W770203 | 1-Oleoyl-2-linoleoyl-rac-glycerol-d5 | / | Unkown | |
| HY-W777094 | 1-Acetyl-4-(4-hydroxyphenyl)piperazine-d8 | / | Unkown | |
| HY-W777620 | 1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone-13C,d3 | / | Unkown | |
| HY-W777706 | 1-(3,4-Dimethylphenyl)ethan-1-ol-13C,d3 | / | Unkown | |
| HY-W778692 | 1-Linoleoyl Glycerol-d5 | / | Unkown | |
| HY-W778954 | 2,2-Dimethyl-1,3-dioxolane-4-methanol-13C3 | / | Unkown | |
| HY-Y0001S1 | Cyclopropylcarboxylic acid-d1 | / | Unkown | |
| HY-Y0093S | NSC 5416-d14 | / | Unkown | |
| HY-Y0219S | 1,2,4-Triazole-13C2,15N3 | / | Unkown | |
| HY-Y0219S1 | 1,2,4-Triazole-d3 | 99.8% | Unkown | |
| HY-Y0531S | 1-Adamantanol-d15 | / | Unkown | |
| HY-Y0727S | 1,5-Dibromopentane-d4 | / | Unkown | |
| HY-Y0727S1 | 1,5-Dibromopentane-d10 | / | Unkown | |
| HY-Y0860S | 1,6-Dibromo-n-hexane-d12 | / | Unkown | |
| HY-Y0921S1 | (±)-1,2-Propanediol-d2 | / | Unkown | |
| HY-Y0921S3 | (±)-1,2-Propanediol-13C3 | / | Unkown | |
| HY-Y1004S3 | 1-Decanol-d5 | / | Unkown | |
| HY-Y1039S | 1-Stearoyl-rac-glycerol-d40 | / | Unkown | |
| HY-Y1044S | 1,5-Dihydroxypentane-d10 | / | Unkown | |
| HY-Y1139S | Pimelic acid-d4 | / | Unkown | |
| HY-Y1217S | 1-Cyclohexanol-d12 | / | Unkown | |
| HY-Y1227S | 1-Methoxy-2-(2-methoxyethoxy)ethane-d14 | / | Unkown | |
| HY-Y1309S | 1-Naphthol-d8 | / | Unkown | |
| HY-Y1641S | 1,2-Ethanedithiol-d4 | / | Unkown | |
| HY-Y1772S | 1-Iodo-4-methylbenzene-d7 | / | Unkown | |
| HY-Y1809S | 1-Hydroxyoctadecane-d37 | / | Unkown | |
| HY-Y1809S1 | 1-Hydroxyoctadecane-d2 | / | Unkown | |
| HY-109037S2 | Mavacamten-d1 | Modulator | / | Unkown |
| HY-112675S | 4-Octyl itaconate-13C5-1 | / | Unkown | |
| HY-113482S | 1β-Hydroxydeoxycholic acid-d5 | / | Unkown | |
| HY-114553S | 1-(5-Fluoropentyl)-1H-indole-3-carboxylic acid-d5 | / | Unkown | |
| HY-124891S | 1-Phenylpyrrole-d9 | / | Unkown | |
| HY-128429S | trans-2-Hexenal-d2-1 | Inhibitor | / | Unkown |
| HY-128792S | 1,3-Dipalmitin-d6 | 98.0% | Unkown | |
| HY-130462S2 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-13C16 | / | Unkown | |
| HY-130462S3 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d64 | / | Unkown | |
| HY-13331S2 | Clascoterone-d5-1 | Antagonist | / | Unkown |
| HY-134178S1 | 5-F-UTP-13C,19F,d1 | / | Unkown | |
| HY-13631ES2 | Deruxtecan-d4-1 | / | Unkown | |
| HY-141636S | 1-PalMitoyl-2-arachidoyllecithin-d9-1 | / | Unkown | |
| HY-145473S | 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE-d11 | / | Unkown | |
| HY-14649S6 | Retinoic acid-d3-1 | Agonist | / | Unkown |
| HY-146829S | 1-Pentadecanoyl-2-oleoyl-sn-glycero-3-phosphate-d7 sodium | / | Unkown | |
| HY-17043S2 | Loratadine-d4-1 | / | Unkown | |
| HY-19822S1 | Elacestrant-d4-1 | Inhibitor | / | Unkown |
| HY-34487S3 | 1,3-Dimethoxybenzene-d3 | / | Unkown | |
| HY-41700S2 | D-Alanine-d1 | / | Unkown | |
| HY-78004S1 | 1,2-Diphenylethane-d4 | / | Unkown | |
| HY-79779S | 1-Bromo-4-(bromomethyl)benzene-d6 | 99.56% | Unkown | |
| HY-B0122SS1 | Topiramate-13C6-1 | / | Unkown | |
| HY-B0141S6 | Estradiol-d2-1 | Agonist | / | Unkown |
| HY-B0197S | Naratriptan-d3 | Agonist | / | Unkown |
| HY-B0258S1 | Gemfibrozil-d6-1 | / | Unkown | |
| HY-B0479S1 | Thiamphenicol-d3-1 | 99.0% | Unkown | |
| HY-B0801S4 | Fexofenadine-d3-1 | Antagonist | / | Unkown |
| HY-B1812S4 | Veratrole-d2-1 | Substrate | / | Unkown |
| HY-D0837S | Imidazole-d4 | 99.94% | Unkown | |
| HY-N0229S19 | L-Alanine-1,2-13C2-1 | / | Unkown | |
| HY-N7092S23 | D-Fructose-13C3-1 | / | Unkown | |
| HY-RS18793 | Sub1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25282 | Sub1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W009293S | 1-(Bis(4-fluorophenyl)methyl)piperazine-d4 | / | Unkown | |
| HY-W011885S | 1-Dodecylpyrrolidin-2-one-d6 | / | Unkown | |
| HY-W012477S | 1-Hydroxycyclohexyl phenyl ketone-d5 | / | Unkown | |
| HY-W012652S | 1,2,3,4-Tetrahydroquinoxaline-d4 | / | Unkown | |
| HY-W015609S | 1-(2-Methoxyphenyl)ethanone-d3 | / | Unkown | |
| HY-W016152S | 1-Bromo-3-methoxybenzene-d3 | / | Unkown | |
| HY-W032013S2 | 1-Octanol-d2-1 | Inhibitor | / | Unkown |
| HY-W032013S3 | 1-Octanol-d5 | Inhibitor | / | Unkown |
| HY-W040193S1 | DSPC-d74 | 99% | Unkown | |
| HY-W110726S | 1-Octen-3-one-d5 | / | Unkown | |
| HY-W110726S1 | 1-Octen-3-one-d3 | / | Unkown | |
| HY-W192474S | 1-(Furan-2-yl)ethane-1-thiol-d3 | / | Unkown | |
| HY-W285163S | 1-Cyclopropyl-6-fluoro-7-(4-formylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid-d8 | / | Unkown | |
| HY-W342440S | 1,1-Diethoxynonane-d10 | / | Unkown | |
| HY-W654320 | Piperin-d10 | / | Unkown | |
| HY-W654409 | 1,1,1,3,3,3-Hexafluoropropan-2-ol-d2 | / | Unkown | |
| HY-W662572S | Pyroxsulam-d6 | / | Unkown | |
| HY-W743123 | 1,3-Dipalmitin-d5 | / | Unkown | |
| HY-W756596 | 1,2-Dioctanoyl-3-chloropropanediol-d5 | / | Unkown | |
| HY-W762019S | 1,2,3,4,7,8-Hexachloro dibenzo-p-dioxin-13C12 | / | Unkown | |
| HY-W777599 | (±)-Naproxen-13C,d3-1 | / | Unkown | |
| HY-W777649 | Oxypurinol-13C,15N2-1 | Inhibitor | / | Unkown |
| HY-Y0045S | 2-Acetylthiazole-13C2 | / | Unkown | |
| HY-Y0659S | 1,2,3,4-Hydroquinoline-d2 | / | Unkown | |
| HY-Y0678S | 1,3,5-Trimethoxybenzene-d3 | / | Unkown | |
| HY-Y0743S | 1-(Pyridin-2-yl)ethan-1-one-d6 | / | Unkown | |
| HY-Y1004S | 1-Decanol-d3 | / | Unkown | |
| HY-Y1004S1 | 1-Decanol-d2 | / | Unkown | |
| HY-Y1309S1 | 1-Naphthol-d7 | 99.44% | Unkown | |
| HY-Y1805S | 1,2,3,4-Tetrahydronaphthalene-d4 | / | Unkown |
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Mus musculus | SUB1 | MGD | MGI:104811 |
| Rattus norvegicus | SUB1 | RGD | RGD:621582 |
| Bos taurus | SUB1 | VGNC | VGNC:35454 |
| Macaca mulatta | SUB1 | VGNC | VGNC:110431 |
| Others | SUB1 | NCBI |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service